Abstract
We scrutinize the evolution of Covid-19 in Madagascar by comparing results from three approaches (cubic polynomial, semi-gaussian and gaussian-like models) which we use to provide an analytical form of the spread of the pandemic. In so doing, we introduce (for the first time) the ratio of the cumulative and daily numbers of infected persons over the corresponding one of tests which are expected to be less sensitive to the number of the tests because the credibility of the results based only on the absolute numbers often raises some criticisms. We also give and compare the reproduction number Reff from different approaches and with the ones with the ones of some European countries with a small number of population (Greece, Switzerland) and some other African countries. Finally, we show and comment the evolution of the total number of deaths and of the per cent number of cured persons and discuss the performance of the medical care.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
This work reports on data analysis of the spread of Covid-19 and does not need a trial ID
Funding Statement
This work has not received any fundings
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This work is a theoretical analysis of the data of the spread of Covid-19 and does not need an IRB number
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
maltezos{at}central.ntua.gr (S. Maltezos)
Data Availability
The data is available from WHO's site